₹ 3532.8
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Target Price
The average target price of TORNTPHARM.NS is 4037 and suggests 14% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recomm
